Cargando…

Patients with Pseudoallergic Reactions Following COVID-19 Vaccination are Able to Tolerate Subsequent Dosing

Detalles Bibliográficos
Autores principales:	Patterson, Alexander, Kendall, Peggy, Monroy, Jennifer, Pham, Christine, Ren, Zhen, Jerath, Maya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804518/ http://dx.doi.org/10.1016/j.jaci.2021.12.578

Ejemplares similares

Histamine Intolerance—A Kind of Pseudoallergic Reaction
por: Zhao, Ying, et al.
Publicado: (2022)

M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
por: Patterson, A., et al.
Publicado: (2021)

Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions
por: Szebeni, János, et al.
Publicado: (2020)

PD31 - Pseudoallergic reactions to food and drugs in children with chronic idiopathic urticaria
por: Ghiordanescu, Ileana-Maria, et al.
Publicado: (2014)

Allantoin Inhibits Compound 48/80-Induced Pseudoallergic Reactions In Vitro and In Vivo
por: Zhang, Ping, et al.
Publicado: (2022)

Formononetin Inhibits Mast Cell Degranulation to Ameliorate Compound 48/80-Induced Pseudoallergic Reactions
por: Zhou, Zi-Wen, et al.
Publicado: (2023)

Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines
por: Marchi, Francesco, et al.
Publicado: (2023)

Forsythoside A and Forsythoside B Contribute to Shuanghuanglian Injection-Induced Pseudoallergic Reactions through the RhoA/ROCK Signaling Pathway
por: Han, Jiayin, et al.
Publicado: (2019)

P2X4 receptor stimulation enhances MrgprB2-mediated mast cell activation and pseudoallergic reactions in mice
por: Yoshida, Kazuki, et al.
Publicado: (2022)

Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction
por: Eastman, Jacqueline, et al.
Publicado: (2022)

Influenza vaccine is able to prevent neuroinflammation triggered by H7N7 IAV infection
por: Demuth, Luisa, et al.
Publicado: (2023)

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience
por: Puxkandl, Viktoria, et al.
Publicado: (2022)

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
por: Woodcock, Victoria K, et al.
Publicado: (2018)

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
por: Moral, Angel, et al.
Publicado: (2016)

Immediate Hypersensitivity Reaction Related to Rabies Post-Exposure-Prophylaxis in Thailand with Subsequent Rabies Vaccine Change to Avoid Polygeline Vaccine Excipient with Successful Challenge and Treatment Tolerance in the United States
por: Beckham, J Michael, et al.
Publicado: (2017)

Abl Is Able to Inhibit Cell Engulfment
por: Robinson, Richard
Publicado: (2009)

Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination
por: Doss, Alexa, et al.
Publicado: (2022)

Monoclonal antibody infusion for COVID-19 infection: results from a tertiary referral center
por: Voelker, Dayne, et al.
Publicado: (2022)

27. Immunologic Hyporesponsiveness with Subsequent Dosing of Meningococcal Vaccines: Re-Evaluating the Current Paradigm
por: Findlow, Jamie, et al.
Publicado: (2021)

The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants
por: Birk, Nina Marie, et al.
Publicado: (2017)

Why some people tolerate the second dose of a vaccine but not the first dose
por: Yu, Yihua Bruce, et al.
Publicado: (2022)

TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING
por: Hamel, B., et al.
Publicado: (2022)

Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Perfectly Able
por: International, Lighthouse
Publicado: (2010)

Synthesis of Trimeric Organozinc Compounds and their Subsequent Reaction with Oxygen
por: Manzi, Joe A., et al.
Publicado: (2016)

Tixagevimab and Cilgavimab (Evusheld – AstraZeneca) efficacy in preventing COVID infection in immunocompromised patients
por: Miot, Christelle, et al.
Publicado: (2023)

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination
por: Jones, Jill K, et al.
Publicado: (2023)

SAT-599 Propylthiouracil-Induced Anaphylaxis with Subsequent Tolerance of Methimazole
por: Liu, Angela, et al.
Publicado: (2019)

Autoantigen-Specific B-Cell Depletion Overcomes Failed Immune Tolerance in Type 1 Diabetes
por: Henry, Rachel A., et al.
Publicado: (2012)

BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance
por: Parker, W T, et al.
Publicado: (2013)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Case Report: Takotsubo Syndrome Induced by Severe Anaphylactic Reaction During Anesthesia Induction and Subsequent High-Dose Epinephrine Resuscitation
por: Wei, Jiaojiao, et al.
Publicado: (2022)

Case of Small-Pox Subsequent to Vaccination
por: Barlow, James
Publicado: (1811)

Influenza vaccine and subsequent development of zoster
por: Wei, Kai‐Che, et al.
Publicado: (2022)

Calculation of delivered composite dose from Calypso tracking data for prostate cancer: And subsequent evaluation of reasonable treatment interruption tolerance limits
por: Zhao, Hui, et al.
Publicado: (2019)

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series
por: Iaboni, Aled, et al.
Publicado: (2022)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
por: Hastert, Florian D., et al.
Publicado: (2022)

Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
por: Alenazy, Leila A., et al.
Publicado: (2022)

Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
por: Baum, Karina J, et al.
Publicado: (2008)

An Able Provincial Chairman
Publicado: (1913)

Cannot write session to /tmp/vufind_sessions/sess_ngrqg86lgsmndug11dvjgul0nn